Company Confirms FY26 Revenue Outlook of $6B to $6.2B
Backs FY26 revenue view $6B-$6.2B, consensus $6.14B. "Our expanded scale combined with our continued focus on strengthening our competitive position and driving profitable growth supports our confidence in our ability to execute against our objectives. While the broader operating environment remains uncertain, we believe our low-cost vertically integrated business model and the agility it provides, together with strong industry positioning provide a solid foundation to navigate evolving external conditions and support continued financial performance. Based on these factors and subject to prevailing macroeconomic conditions, we believe we are well positioned to progress toward the three-year objectives for the 2026-2028 period as outlined in our Q4 earnings release issued on February 26, 2026."
Trade with 70% Backtested Accuracy
Analyst Views on GIL
About GIL
About the author

- FIGS Market Performance: In FY 2025, FIGS reported revenue of $631.1 million, a 13.6% increase, with a net income of approximately $34.2 million, indicating strong brand expansion in the healthcare apparel market, although it faces operational risks due to reliance on a single fulfillment center in Arizona.
- Gildan's Steady Growth: Gildan achieved revenue of about $3.7 billion in FY 2025, a 12.5% increase, with a net income of approximately $405.9 million and a net margin of 11.0%, benefiting from a large-scale vertically integrated manufacturing model that ensures stable profitability in a competitive market.
- Risk Analysis: FIGS faces challenges from supply chain concentration and geopolitical risks, particularly with its main production bases in Vietnam and Jordan, while Gildan is affected by raw material price volatility and international trade policies, although its multi-brand strategy provides some buffer.
- Valuation Comparison: FIGS has a forward P/E ratio of 45.2, significantly higher than Gildan's 13.4, indicating that while FIGS shows higher growth potential, its elevated valuation may pose greater risks for investors, whereas Gildan offers a more attractive value investment opportunity.
- FIGS Growth Potential: In FY 2025, FIGS reported revenue of $631.1 million, a 13.6% increase, with net income soaring to $34.2 million, indicating strong brand loyalty and market expansion in the healthcare apparel sector.
- Gildan Stability: Gildan achieved approximately $3.7 billion in revenue for the same fiscal year, with a net income of $405.9 million and a net margin of 11%, showcasing its robust profitability and stable market position in the basic apparel segment.
- Operational Risk Comparison: FIGS relies on a single fulfillment center in Arizona, making it vulnerable to disruptions that could impact product delivery, while Gildan's vertically integrated manufacturing model mitigates such risks, ensuring higher supply chain stability.
- Market Competition Landscape: FIGS faces intense competition from traditional wholesalers like Barco Uniforms, whereas Gildan competes with large manufacturers like Hanesbrands in the everyday apparel market, highlighting their distinctly different market strategies.
- Shareholder Rights Investigation: The Schall Law Firm is investigating Gildan Activewear Inc. for potential violations of securities laws, focusing on whether the company issued false or misleading statements and failed to disclose information critical to investors, which could lead to shareholder losses.
- CEO Dismissal Impact: Gildan announced the termination of CEO Glenn Chamandy on December 11, 2023, resulting in a 10% drop in share price, indicating a strong market reaction to management changes that may undermine investor confidence.
- Proxy Battle Outcome: Following a proxy battle, Chamandy was reinstated while the board of directors departed, suggesting instability in corporate governance that could further affect shareholder investment decisions and company performance.
- Legal Consultation Opportunity: The Schall Law Firm encourages affected shareholders to reach out for free consultations regarding their rights, demonstrating the firm's commitment to protecting investor interests while potentially attracting more shareholders to participate in the lawsuit.
- Earnings Growth Potential: UBS analyst Jay Sole highlights that Gildan (GIL) could see a 16% compound annual growth rate in earnings per share over the next five years following its acquisition of Hanesbrands, significantly enhancing the company's profitability.
- Expanded Market Opportunities: The Hanesbrands acquisition broadens Gildan's addressable market beyond traditional T-shirts and sweatshirts to include bags, jackets, and sports performance apparel, which is expected to drive direct sales growth.
- Cost Advantage Realization: Gildan's factories in Central America provide a cost edge over competitors reliant on Asia, particularly in the current tariff environment, potentially attracting more brand partnerships to lower costs.
- Synergies Coming to Light: Gildan anticipates $250 million in synergies by fiscal 2028, primarily from moving Hanesbrands production to its more efficient factories, with financial benefits expected to start materializing in fiscal 2027.
- CEO Dismissal Incident: On December 11, 2023, Gildan Activewear abruptly terminated co-founder and CEO Glenn Chamandy, resulting in a 10% drop in GIL shares in a single session, from $35.14 to $31.35, causing significant losses for shareholders.
- High Expenses: Over the following six months, Gildan incurred more than $77 million in expenses related to a proxy battle, highlighting severe governance issues and the oppression of shareholder rights.
- Shareholder Reinstatement Vote: Following a high-profile proxy battle, shareholders voted on May 28, 2024, to reinstate Chamandy and elect a new board of directors, marking a significant shift in corporate governance.
- Management Changes: After the appointment of Vince Tyra as interim CEO, all members of the old board departed, reflecting a major restructuring in governance and leadership aimed at restoring shareholder confidence and improving the company's outlook.









